» Articles » PMID: 28339618

Telomere Length, Oxidative Stress, Inflammation and BDNF Levels in Siblings of Patients with Bipolar Disorder: Implications for Accelerated Cellular Aging

Abstract

Background: Growing evidence supports the existence of neurobiological trait abnormalities in individuals at genetic risk for bipolar disorder. The aim of this study was to examine potential differences in brain-derived neurotrophic factor, cytokines, oxidative stress, and telomere length markers between patients with bipolar disorder, their siblings, and healthy controls.

Methods: Thirty-six patients with bipolar disorder type I, 39 siblings, and 44 healthy controls were assessed. Serum levels of brain-derived neurotrophic factor, interleukin-6, interleukin-10, tumor necrosis factor-α, C-C motif chemokine 11, C-C motif chemokine 24, and 3-nitrotyrosine were measured, as were the activities of glutathione peroxidase, glutathione reductase, and glutathione S-transferase. Telomere length (T/S ratio) was measured using quantitative polymerase chain reaction.

Results: Telomere length was different between the 3 groups (P = .041) with both patients and siblings showing a shorter T/S ratio compared with healthy controls. Patients showed increased levels of interleukin-6 (P = .005) and interleukin-10 (P = .002) compared with controls as well as increased levels of interleukin-6 (p = 0.014) and CCL24 (P = .016) compared with their siblings. C-C motif chemokine 11 levels were increased in siblings compared with controls (P = .015), and a similar tendency was found in patients compared with controls (P = .045). Glutathione peroxidase activity was decreased in patients compared with controls (P = .006) and siblings (P = .025). No differences were found for the other markers.

Conclusions: The present results suggest that unaffected siblings may present accelerated aging features. These neurobiological findings may be considered as endophenotypic traits. Further prospective studies are warranted.

Citing Articles

Immune dysregulation in bipolar disorder.

Argue B, Casten L, McCool S, Alrfooh A, Richards J, Wemmie J J Affect Disord. 2025; 374:587-597.

PMID: 39818340 PMC: 11830520. DOI: 10.1016/j.jad.2025.01.062.


Influence of subclinical hypothyroidism and brain-derived neurotropic factor on telomere length dynamics in type 1 diabetic pregnancies and their newborns.

Djelmis J, Ivanisevic M Sci Rep. 2025; 15(1):194.

PMID: 39747616 PMC: 11696295. DOI: 10.1038/s41598-024-84430-z.


Psychoneuroimmunology of Mood Disorders.

Teixeira A, Scholl J, Bauer M Methods Mol Biol. 2024; 2868:49-72.

PMID: 39546225 DOI: 10.1007/978-1-0716-4200-9_4.


Putative Risk Biomarkers of Bipolar Disorder in At-risk Youth.

Meng X, Zhang S, Zhou S, Ma Y, Yu X, Guan L Neurosci Bull. 2024; 40(10):1557-1572.

PMID: 38710851 PMC: 11422403. DOI: 10.1007/s12264-024-01219-w.


Mitochondrial DNA oxidation, methylation, and copy number alterations in major and bipolar depression.

Ceylan D, Karacicek B, Tufekci K, Aksahin I, Senol S, Genc S Front Psychiatry. 2024; 14:1304660.

PMID: 38161720 PMC: 10755902. DOI: 10.3389/fpsyt.2023.1304660.


References
1.
Ellenbogen M, Santo J, Linnen A, Walker C, Hodgins S . High cortisol levels in the offspring of parents with bipolar disorder during two weeks of daily sampling. Bipolar Disord. 2010; 12(1):77-86. DOI: 10.1111/j.1399-5618.2009.00770.x. View

2.
Salpea K, Talmud P, Cooper J, Maubaret C, Stephens J, Abelak K . Association of telomere length with type 2 diabetes, oxidative stress and UCP2 gene variation. Atherosclerosis. 2009; 209(1):42-50. PMC: 2839074. DOI: 10.1016/j.atherosclerosis.2009.09.070. View

3.
Chan S, Blackburn E . Telomeres and telomerase. Philos Trans R Soc Lond B Biol Sci. 2004; 359(1441):109-21. PMC: 1693310. DOI: 10.1098/rstb.2003.1370. View

4.
Fries G, Vasconcelos-Moreno M, Gubert C, Dos Santos B, Sartori J, Eisele B . Hypothalamic-pituitary-adrenal axis dysfunction and illness progression in bipolar disorder. Int J Neuropsychopharmacol. 2014; 18(1). PMC: 4368875. DOI: 10.1093/ijnp/pyu043. View

5.
Magalhaes P, Jansen K, Stertz L, Ferrari P, Pinheiro R, da Silva R . Peripheral eotaxin-1 (CCL11) levels and mood disorder diagnosis in a population-based sample of young adults. J Psychiatr Res. 2013; 48(1):13-5. DOI: 10.1016/j.jpsychires.2013.10.007. View